Response to: Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion by Schroff et al.,


Dear Editor, We thank the authors for their interest in our study. We agree that combined treatment with triamcinolone could reduce the number of recurrent treatments with bevacizumab. However, the combination treatment did not seem to change the visual acuity outcome compared to previously published reports with bevacizumab monotherapy. The reduced number… (More)
DOI: 10.1007/s00417-010-1354-5


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics